Vutrisiran reduces mortality in transthyretin amyloidosis with cardiomyopathy
1. Vutrisiran treatment reduced the risk of death and recurrent cardiovascular events compared to placebo in patients with transthyretin amyloidosis ...
1. Vutrisiran treatment reduced the risk of death and recurrent cardiovascular events compared to placebo in patients with transthyretin amyloidosis ...
1. In this randomized controlled trial, spironolactone did not significantly reduce death from cardiovascular causes or new or worsening heart ...
1. In this randomized controlled trial, in patients who had a myocardial infarction, a three-year treatment with colchicine was not ...
1. In this phase one clinical trial, among patients with transthyretin amyloid cardiomyopathy (ATTR-CM), it was found that nexiguran ziclumeran ...
1. In this randomized controlled trial, insulin alfa efsitora (efsitora) demonstrated noninferiority to degludec in reducing glycated hemoglobin (HbA1c) levels ...
1. In patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) with stable coronary artery disease (CAD), ...
1. In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), invasive treatment did not significantly ...
1. A randomized controlled trial by Lin and colleagues compared artificial intelligence (AI) to standard care in triaging suspected cases ...
Click here to read this study in JAMA.
In a large cohort of hospitalized patients in Maryland, it was found that Black patients with aortic stenosis had a ...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in